Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul-Aug;38(6):1436-1440.
doi: 10.12669/pjms.38.6.5251.

Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy

Mehnaz Khakwani  1 , Rashida Parveen  2 , Syeda Ali  3
Affiliations

Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy

Mehnaz Khakwani et al. Pak J Med Sci. 2022 Jul-Aug.

Abstract

Objectives: To compare the success rates and safety of two-doses of methotrexate versus single dose of methotrexate in ectopic tubal pregnancy.

Methods: This was an open-label, randomized controlled trial done at "The Department of Obstetrics & Gynecology, Nishtar University Hospital, Multan" from January 2020 to July 2021. A total of 100 women (50 in each group), aged 20 to 35 years with a tubal ectopic pregnancy were enrolled. All patients were randomly allocated to either single-dose or two-dose methotrexate protocol. Cases were evaluated for treatment success, side effects, beta-human chorionic gonadotrophin (β-hCG) resolution time and treatment satisfaction.

Results: In a total of 100 cases, mean age was 29.6±4.5 years. Mean serum β -hCG levels at baseline was 1212±78 mIU/ml. Treatment success was noted among 43 (86.0%) cases of single-dose group versus 45 (90.0%) cases (p=0.5382). Duration of β -hCG resolution time was significantly shorter in two-dose group (23.0±12.1 days versus 28.2±12.8 days, p=0.0394). No significant difference was noted in methotrexate associated side effects in both study groups (p=0.9996). Overall, mean satisfaction score was 4.0±1.3 (out of 5).

Conclusion: Although, β -hCG resolution time was significantly low in two-dose protocol but single-dose methotrexate offered comparable success rates versus two-dose protocol. Side effects were mild and comparable in both methotrexate treatment protocols. Methotrexate was found to be effective in the medical management of ectopic pregnancy.

Keywords: Beta-human chorionic gonadotrophin; Ectopic pregnancy; Methotrexate.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Figures

Fig.1
Fig.1
Methodology flow chart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. O'Herlihy C. Reviewing maternal deaths to make motherhood safer:2006–2008. BJOG. 2011;118:1403–1404. - PubMed
    1. Helvacioglu C, Dogan K. Predictive factors of treatment success in two-dose methotrexate regimen in ectopic tubal pregnancy:A retrospective study. Pak J Med Sci. 2021;37(5):1309–1312. doi:10.12669/pjms.37.5.4299. - PMC - PubMed
    1. Tug N, Sargin MA, Yassa M. Multidose Methotrexate treatment of ectopic pregnancies with high initial β-human chorionic gonadotropin:can success be predicted? Gynecol Obstet Invest. 2019;84(1):56–63. doi:10.1159/000491083. - PubMed
    1. American College of Obstetricians and Gynecologists'Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No 193:Tubal Ectopic Pregnancy. Obstet Gynecol. 2018;131(3):e91–e103. doi:10.1097/AOG.0000000000002560. - PubMed
    1. Yang C, Cai J, Geng Y, Gao Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy:a systematic review and meta-analysis. Reprod Biomed Online. 2017;34(4):383–391. doi:10.1016/j.rbmo.2017.01.004. - PubMed

LinkOut - more resources